Hexanedione | CAS:3848-24-6

We serve Hexanedione CAS:3848-24-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Hexanedione

CAS No: 3848-24-6
Product Name: Hexanedione
Other Name:
Hexanedione
Hexane-2,3-dione
Acetyl butyryl
2,3-Hexanedione
 
Density: 0.9±0.1 g/cm3
Boiling Point: 125.0±9.0 °C at 760 mmHg
Melting Point: -30 °C
Molecular Formula: C6H10O2
Molecular Weight: 114.142
Flash Point: 32.8±4.4 °C
Exact Mass: 114.068077
PSA: 34.14000
LogP: -0.27
Vapour density: 3.9 (vs air)
Vapour Pressure: 12.4±0.2 mmHg at 25°C
Index of Refraction: 1.406
Storage condition: Flammables area
Stability: Stable. Flammable. Incompatible with strong bases, strong oxidizing agents.
 
Specification:
Odor: Sweet cream, caramel odor
Appearance: Yellow oily liquid
Assay: ≥98.0%
 
Application:
Food additives; food flavors; flavor enhancers.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3-Hydroxybutanoic acid calcium salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-Hexanedione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-Hexanedione Use and application,Calcium beta-hydroxybutyrate technical grade,usp/ep/jp grade.


Related News: Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).2-(Methylsulfonyl)ethylamine Hydrochloride manufacturer Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).3-bromopiperidine-2,6-dione supplier The resort island of Jeju off the south coast of South Korea, a popular destination for Chinese tourists, is temporarily suspending the 30-day no-visa entry that it was granting to Chinese and other foreign tourists.4-(3,4-Dichloro Phenyl)-Tetralone vendor The resort island of Jeju off the south coast of South Korea, a popular destination for Chinese tourists, is temporarily suspending the 30-day no-visa entry that it was granting to Chinese and other foreign tourists.The resort island of Jeju off the south coast of South Korea, a popular destination for Chinese tourists, is temporarily suspending the 30-day no-visa entry that it was granting to Chinese and other foreign tourists.